+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Keloid Treatment Market (2021 - 2026)

  • PDF Icon


  • 132 Pages
  • January 2021
  • Region: Global
  • IndustryARC
  • ID: 3974150
Keloid scars are heap-up scars which are developed with injuries causing due to, acne, burns, ear piercing, chickenpox, surgical cuts, scratches and vaccination sites and build up abruptly on the skin surface. Keloid scars develop commonly in people between age group 10 to 20 years of age. Globally, development of advance technology based treatment, rise in the appearance consciousness, and increasing awareness about scare treatment products, and expenditure on personal care, and changing lifestyle are the prime growth drivers of global keloid treatment market. In addition, increase in adoption of of radiation therapy, surgical intervention, and steroid injections and, emerging economies such as China, India and others, will create new opportunities for global keloid treatment market. However, higher cost of treatment, and risk of side effects and complications during treatment are the key restraints for global keloid treatment market.

This report identifies the global keloid treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global keloid treatment market.

Geographically North America dominated global keloid treatment market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing disposable income, rising focus on personal well-being and modernizing healthcare infrastructure in this region. Among all the treatments, surgical treatment segment has the highest market share in global keloid treatment market.

This report segments global keloid treatment market on the basis of product, treatment, and regional market as follows:

  • Keloid Treatment Market, By Product: Elastic Wraps, Sprays, Ointment, Creams, Oils, and Topical Gels & Gel Sheets
  • The report has focused study on keloid treatment market by basis of treatment such as: Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Steroid Injections, and Interferon
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the keloid treatment market. Some of the major companies’ profiles in detail are as follows:

  • Bristol-Myers Squibb Company
  • Valeant Pharmaceuticals International Inc.
  • Renovo Group Plc
  • Galena Biopharma, Inc.
  • Pacific World Corporation

Table of Contents

1. Keloid Treatment Market - Overview
1.1. Definitions and Scope
2. Keloid Treatment Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Keloid Treatment Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis
4. Keloid Treatment Market Forces
4.1. Drivers
4.2. Constraints
4.3. Challenges
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes
5. Keloid Treatment Market - Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share
6. Keloid Treatment Market - By Product (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.1. Elastic Wraps
6.3.2. Sprays
6.3.3. Ointment
6.3.4. Creams
6.3.5. Oils
6.3.6. Topical Gels & Gel Sheets
7. Keloid Treatment Market - By Treatment (Market Size -$Million / $Billion)
7.1. Radiation Therapy
7.2. Cry Therapy
7.3. Surgical Treatment
7.4. Laser Treatment
7.5. Steroid Injections
7.6. Interferon
8. Keloid Treatment - By Geography (Market Size -$Million / $Billion)
8.1. Keloid Treatment Market - North America Segment Research
8.2. North America Market Research (Million / $Billion)
8.2.1. Segment type Size and Market Size Analysis
8.2.2. Revenue and Trends
8.2.3. Application Revenue and Trends by type of Application
8.2.4. Company Revenue and Product Analysis
8.2.5. North America Product type and Application Market Size U.S. Canada Mexico Rest of North America
8.3. Keloid Treatment - South America Segment Research
8.4. South America Market Research (Market Size -$Million / $Billion)
8.4.1. Segment type Size and Market Size Analysis
8.4.2. Revenue and Trends
8.4.3. Application Revenue and Trends by type of Application
8.4.4. Company Revenue and Product Analysis
8.4.5. South America Product type and Application Market Size Brazil Venezuela Argentina Ecuador Peru Colombia Costa Rica Rest of South America
8.5. Keloid Treatment - Europe Segment Research
8.6. Europe Market Research (Market Size -$Million / $Billion)
8.6.1. Segment type Size and Market Size Analysis
8.6.2. Revenue and Trends
8.6.3. Application Revenue and Trends by type of Application
8.6.4. Company Revenue and Product Analysis
8.6.5. Europe Segment Product type and Application Market Size U.K Germany Italy France Netherlands Belgium Spain Denmark Rest of Europe
8.7. Keloid Treatment - APAC Segment Research
8.8. APAC Market Research (Market Size -$Million / $Billion)
8.8.1. Segment type Size and Market Size Analysis
8.8.2. Revenue and Trends
8.8.3. Application Revenue and Trends by type of Application
8.8.4. Company Revenue and Product Analysis
8.8.5. APAC Segment - Product type and Application Market Size China Australia Japan South Korea India Taiwan Malaysia
9. Keloid Treatment Market - Entropy
9.1. New product launches
9.2. M&A's, collaborations, JVs and partnerships
10. Keloid Treatment Market Company Analysis
10.1. Market Share, Company Revenue, Products, M&A, Developments
10.2. Bristol-Myers Squibb Company
10.3. Valeant Pharmaceuticals International Inc.
10.4. Renovo Group Plc
10.5. Galena Biopharma, Inc.
10.6. Pacific World Corporation
10.7. RXi Pharmaceuticals, Inc.
10.8. Novartis AG
10.9. GlaxoSmithKline plc
10.10. Revitol Corporation Inc.
10.11. Avita Medical Limited
*Financials would be provided on a best efforts basis for private companies
11. Keloid Treatment Market - Appendix
11.1. Abbreviations
11.2. Sources
12. Keloid Treatment Market - Methodology
12.1. Research Methodology
12.1.1. Company Expert Interviews
12.1.2. Industry Databases
12.1.3. Associations
12.1.4. Company News
12.1.5. Company Annual Reports
12.1.6. Application Trends
12.1.7. New Products and Product database
12.1.8. Company Transcripts
12.1.9. R&D Trends
12.1.10. Key Opinion Leaders Interviews
12.1.11. Supply and Demand Trends